Updated October 16, 2026: This article now includes medical context and distinguishes the Eagles’ confirmed findings from outside analysis.
PHILADELPHIA – Jalen Hurts will miss Sunday’s game against the Carolina Panthers after a follow-up ultrasound showed a change in a superficial blood clot in his calf. The Philadelphia Eagles have not announced his treatment or a return date.
The distinction matters: superficial describes a clot’s location near the skin, not a guarantee that it can be ignored. It also does not mean Hurts has been diagnosed with a deep-vein clot.
In their October 15 statement, the Eagles said Hurts requested calf treatment on October 8 after reporting that he had been cleated against the Rams on October 4. An ultrasound performed in London on Saturday revealed a superficial clot.
The team said its medical staff and doctors in London concluded he could safely play, with activity and mobility considered important. Doctors recommended another ultrasound within 72 hours of the game and return flight. Hurts subsequently practiced in full Wednesday.
Wednesday night’s scan, the club said, “revealed movement in the small blood clot.” That prompted his withdrawal while doctors determined treatment. The statement did not explain the direction of that movement or say the clot had reached a deep vein.
In Jayna Bardahl’s medical explainer, physician Ashwin Rao discussed why proximity to a deep vein could matter. His discussion of possible extension and blood-thinning treatment was outside analysis, not confirmation of Hurts’ condition or medication.
The NHS guidance on superficial thrombophlebitis describes inflammation in veins near the skin that often improves on its own. Treatment varies: some cases require none, while others may warrant medication or professionally fitted compression stockings. Symptoms need assessment because a deeper clot is a different concern.
Those general descriptions cannot establish a professional quarterback’s recovery schedule. Nor does the Eagles’ statement establish that the flight caused the clot or that the initial clearance was improper.
For the Philadelphia Eagles, Hurts’ absence creates an immediate quarterback change. For readers tracking his health, the unanswered questions are narrower: what treatment his doctors choose, what follow-up imaging shows and when they clear him to return. None can be answered from the word “superficial” alone.
